Patents by Inventor Ove Molin

Ove Molin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7524834
    Abstract: The invention provides sterile glucocorticosteroids and sterile formulations containing glucocorticosteroid and use thereof in the treatment of an allergic and/or inflammatory condition of the nose or the lungs.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: April 28, 2009
    Assignee: AstraZeneca AB
    Inventors: Ann-Kristin Karlsson, Cheryl Larrivee-Elkins, Ove Molin
  • Publication number: 20070197489
    Abstract: The invention provides a process for the sterilization of a powdered form of a glucocorticosteroid, sterile glucocorticosteroids, sterile formulations containing glucocorticosteroids and use thereof in the treatment of an allergic and/or inflammatory condition of the nose or lungs.
    Type: Application
    Filed: March 23, 2007
    Publication date: August 23, 2007
    Inventors: Ann-Kristin Karlsson, Cheryl Larrivee-Elkins, Ove Molin
  • Publication number: 20020065256
    Abstract: The invention provides a process for the sterilization of a powdered form of a glucocorticosteroid, sterile glucocorticosteroids, sterile formulations containing glucocorticosteroids and use thereof in the treatment of an allergic and/or inflammatory condition of the nose or lungs.
    Type: Application
    Filed: November 27, 2001
    Publication date: May 30, 2002
    Inventors: Ann-Kristin Karlsson, Cheryl Larrivee-Elkins, Ove Molin
  • Patent number: 6392036
    Abstract: The invention provides a process for the sterilization of a powdered form of a glucocorticosteroid, sterile glucocorticosteroids, sterile formulations containing glucocorticosteroids and use thereof in the treatment of an allergic and/or inflammatory condition of the nose or lungs.
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: May 21, 2002
    Assignee: AstraZeneca AB
    Inventors: Ann-Kristin Karlsson, Cheryl Larrivee-Elkins, Ove Molin